Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01291264 · ClinicalTrials.gov registry record
Use of Abbott RealTime CT/NG to Detect Chlamydia Trachomatis [CT] & Neisseria Gonorrhoeae [NG] in Men Who Have Sex With Men [MSM]
A clinical trial, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- 260
- Enrollment target
NCT01291264 is a clinical trial that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 260 participants.
The verdict
NCT01291264 was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- 260 participants
- Enrollment target
Study Summary
Julius Schachter, PhD, (Department of Laboratory Medicine, University of California, San Francisco) and Susan S. Philip, MD MPH (Department of Medicine, University of California, San Francisco) are conducting a study to evaluate the Abbott RealTime CT/NG polymerase chain reaction \[PCR\] assay (which is a nucleic acid amplification test \[NAAT\]) for detecting two sexually transmitted bacteria, Chlamydia trachomatis \[CT\] and Neisseria gonorrhoeae \[NG\], using urine samples and swabs from the throat and rectum of men who have sex with men \[MSM\]. Using this test on these swabs is experimental because it has not been approved by the Food \& Drug Administration.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01291264
The ClinicalTrials.gov registry entry for NCT01291264 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01291264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01291264 about?
NCT01291264 is a clinical study titled "Use of Abbott RealTime CT/NG to Detect Chlamydia Trachomatis [CT] & Neisseria Gonorrhoeae [NG] in Men Who Have Sex With Men [MSM]". Julius Schachter, PhD, (Department of Laboratory Medicine, University of California, San Francisco) and Susan S. Philip, MD MPH (Department of Medicine, University of California, San Francisco) are conducting a study to evaluate the Abbott RealTime CT/NG polymerase chain reaction \[PCR\] assay (whic...
What is the current status of trial NCT01291264?
This trial is currently terminated. The enrollment target is 260 participants. The study started on 2012-06. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT01291264?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.